198 related articles for article (PubMed ID: 27020667)
1. A proteomic analysis of mushroom polysaccharide-treated HepG2 cells.
Chai Y; Wang G; Fan L; Zhao M
Sci Rep; 2016 Mar; 6():23565. PubMed ID: 27020667
[TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of down-regulation of oncoprotein DJ-1 and proteasome activator subunit 1 in hepatitis B virus-infected well-differentiated hepatocellular carcinoma.
Zhang D; Lim SG; Koay ES
Int J Oncol; 2007 Sep; 31(3):577-84. PubMed ID: 17671684
[TBL] [Abstract][Full Text] [Related]
3. Comparative proteomic analysis of mouse livers from embryo to adult reveals an association with progression of hepatocellular carcinoma.
Lee NP; Leung KW; Cheung N; Lam BY; Xu MZ; Sham PC; Lau GK; Poon RT; Fan ST; Luk JM
Proteomics; 2008 May; 8(10):2136-49. PubMed ID: 18425728
[TBL] [Abstract][Full Text] [Related]
4. Comparative proteomics and molecular mechanical analysis in CDA-II induced therapy of LCI-D20 hepatocellular carcinoma model.
Fan HZ; Liu H; Zhang C; Gao DM; Xue Q; Chen J; Sun RX; Liu YK; Yang PY
J Cancer Res Clin Oncol; 2009 Apr; 135(4):591-602. PubMed ID: 18853186
[TBL] [Abstract][Full Text] [Related]
5. iTRAQ-Based Quantitative Proteomic Analysis of the Inhibitory Effects of Polysaccharides from Viscum coloratum (Kom.) Nakai on HepG2 Cells.
Chai Y; Zhao M
Sci Rep; 2017 Jul; 7(1):4596. PubMed ID: 28676664
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis and molecular characterization of tissue ferritin light chain in hepatocellular carcinoma.
Park KS; Kim H; Kim NG; Cho SY; Choi KH; Seong JK; Paik YK
Hepatology; 2002 Jun; 35(6):1459-66. PubMed ID: 12029631
[TBL] [Abstract][Full Text] [Related]
7. Proteome Differences between Hepatitis B Virus Genotype-B- and Genotype-C-Induced Hepatocellular Carcinoma Revealed by iTRAQ-Based Quantitative Proteomics.
Wei D; Zeng Y; Xing X; Liu H; Lin M; Han X; Liu X; Liu J
J Proteome Res; 2016 Feb; 15(2):487-98. PubMed ID: 26709725
[TBL] [Abstract][Full Text] [Related]
8. Proteomic identification of CIB1 as a potential diagnostic factor in hepatocellular carcinoma.
Junrong T; Huancheng Z; Feng H; Yi G; Xiaoqin Y; Zhengmao L; Hong Z; Jianying Z; Yin W; Yuanhang H; Jianlin Z; Longhua S; Guolin H
J Biosci; 2011 Sep; 36(4):659-68. PubMed ID: 21857112
[TBL] [Abstract][Full Text] [Related]
9. Proteomic profiling of hepatocellular carcinoma in Chinese cohort reveals heat-shock proteins (Hsp27, Hsp70, GRP78) up-regulation and their associated prognostic values.
Luk JM; Lam CT; Siu AF; Lam BY; Ng IO; Hu MY; Che CM; Fan ST
Proteomics; 2006 Feb; 6(3):1049-57. PubMed ID: 16400691
[TBL] [Abstract][Full Text] [Related]
10. Expression of Raf kinase inhibitor protein in human hepatoma tissues by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionization time-of-flight methods.
Tsao DA; Shiau YF; Tseng CS; Chang HR
Indian J Cancer; 2016; 53(2):216-219. PubMed ID: 28071612
[TBL] [Abstract][Full Text] [Related]
11. Serum and tissue proteomic signatures of patients with hepatocellular carcinoma using 2‑D gel electrophoresis.
Peng H; Yan Z; Zeng X; Zhang S; Jiang H; Huang H; Zhuo H
Mol Med Rep; 2019 Aug; 20(2):1025-1038. PubMed ID: 31173207
[TBL] [Abstract][Full Text] [Related]
12. Combined serum and tissue proteomic study applied to a c-Myc transgenic mouse model of hepatocellular carcinoma identified novel disease regulated proteins suitable for diagnosis and therapeutic intervention strategies.
Ritorto MS; Borlak J
J Proteome Res; 2011 Jul; 10(7):3012-30. PubMed ID: 21644509
[TBL] [Abstract][Full Text] [Related]
13. Proteomics analysis demonstrating rosmarinic acid suppresses cell growth by blocking the glycolytic pathway in human HepG2 cells.
Ma ZJ; Yan H; Wang YJ; Yang Y; Li XB; Shi AC; Jing-Wen X; Yu-Bao L; Li L; Wang XX
Biomed Pharmacother; 2018 Sep; 105():334-349. PubMed ID: 29864622
[TBL] [Abstract][Full Text] [Related]
14. Differential proteomic analysis of hepatocellular carcinoma.
Corona G; De Lorenzo E; Elia C; Simula MP; Avellini C; Baccarani U; Lupo F; Tiribelli C; Colombatti A; Toffoli G
Int J Oncol; 2010 Jan; 36(1):93-9. PubMed ID: 19956837
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of hepatocellular carcinoma HepG2 cells treated with platycodin D.
Lu JJ; Lu DZ; Chen YF; Dong YT; Zhang JR; Li T; Tang ZH; Yang Z
Chin J Nat Med; 2015 Sep; 13(9):673-9. PubMed ID: 26412427
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed proteins of gamma-ray irradiated rat intestinal epithelial IEC-6 cells by two-dimensional gel electrophoresis and matrix-assisted laser desorption/ionisation-time of flight mass spectrometry.
Bo Z; Yongping S; Fengchao W; Guoping A; Yongjiang W
Proteomics; 2005 Feb; 5(2):426-32. PubMed ID: 15700242
[TBL] [Abstract][Full Text] [Related]
17. Detection and identification of peroxiredoxin 3 as a biomarker in hepatocellular carcinoma by a proteomic approach.
Qiao B; Wang J; Xie J; Niu Y; Ye S; Wan Q; Ye Q
Int J Mol Med; 2012 May; 29(5):832-40. PubMed ID: 22344546
[TBL] [Abstract][Full Text] [Related]
18. Comparative proteomic analysis of the hepatic response to heat stress in Muscovy and Pekin ducks: insight into thermal tolerance related to energy metabolism.
Zeng T; Jiang X; Li J; Wang D; Li G; Lu L; Wang G
PLoS One; 2013; 8(10):e76917. PubMed ID: 24116183
[TBL] [Abstract][Full Text] [Related]
19. Proteome alteration of early-stage differentiation of mouse embryonic stem cells into hepatocyte-like cells.
Li Y; Kang X; Guo K; Li X; Gao D; Cui J; Sun L; Yang P; Liu Y
Electrophoresis; 2009 May; 30(9):1431-40. PubMed ID: 19424999
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model.
Tong A; Wu L; Lin Q; Lau QC; Zhao X; Li J; Chen P; Chen L; Tang H; Huang C; Wei YQ
Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
